| Code | 02078 | ||||||||||
| MA number | 41/0875/10-S | ||||||||||
| Product Form: | tbl plg 60x35 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Teva B.V., Netherland | ||||||||||
| Therapeutic Class: | 41 - CARDIACA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 25.11.2010 |
| Dokument: |
Trimetazidin-DemlGroup PR 35mg_vhs.doc
|
| Dokument: |
DHPC Trimetazidin - DG 12_ 11_ 2012.pdf
|
| SPC: |
SPC_Trimetazidin Teva PR 35 mg_tbl plg_10_2025.pdf
|
| PIL: |
PIL_Trimetazidin Teva PR 35 mg_tbl plg_10_2025.pdf
|
| Safety feature | Yes |
| Data update: | 11.11.2019 |
